(Q41071956)

26 September 2017

title

Adjuvant Trial of Levamisole in Patients With Squamous Cancer of the Head and Neck: A Preliminary Report (English)

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

13 April 2023

1 reference

6

H F Oettgen

1 reference

26 September 2017

H. J. Wanebo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A379937

13 April 2023

E. Y. Hilal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A379937

13 April 2023

E. W. Strong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A379937

13 April 2023

C. M. Pinsky

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A379937

13 April 2023

V. Mike

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A379937

13 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=379937

13 April 2023

publication date

1 January 1978

1 reference

full work available at URL

26 September 2017

http://link.springer.com/content/pdf/10.1007/978-3-642-81332-0_49.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Recent Results in Cancer Research

13 April 2023

published in

1 reference

26 September 2017

volume

68

1 reference

26 September 2017

page(s)

324-333

1 reference

Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma

26 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells

13 April 2023

3

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Impaired immunologic reactivity and recurrence following cancer surgery

13 April 2023

4

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Epidermoid carcinoma of the mouth and pharynx 1960–1964

13 April 2023

5

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Immunologic evaluation and prognosis in patients with head and neck cancer

13 April 2023

6

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Nonparametric Estimation from Incomplete Observations

13 April 2023

7

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck

13 April 2023

8

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data

13 April 2023

9

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Levamisole in advanced human breast cancer

13 April 2023

12

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapy

13 April 2023

15

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

T-cell deficiency in patients with squamous cell cancer of the head and neck

13 April 2023

16

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

Adjuvant Trial of Levamisole in Patients With Squamous Cancer of the Head and Neck: A Preliminary Report

13 April 2023

17

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_49

13 April 2023

Identifiers

0 references

1 reference